Recent Comments
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
- Lance W Richardson on The Declaration of Pandemics
- Sarah on The Declaration of Pandemics
- Bill on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (23,219)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (17,499)
- New treatment paradigm for C. Diff colitis (16,009)
- The Healthcare Channel hits 10 (15,370)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,264)
- How the FDA regulates compounding pharmacies (15,075)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,924)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (10,813)
- The new CDC guidelines for prescribing opioid pain pills (10,325)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (10,196)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – Policy
The serious adverse events caused by topical testoserone
March 1, 2014
Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA
Leave a comment
FDA investigated by congress for spying on whistleblowers
Update February 26, 2014- Senator Grassley convened an oversight hearing in the senate, and also
Posted in Congress, FDA
Leave a comment
The FDA discusses Brilinta
February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal
Posted in - Pharma, Cardiology, FDA
Leave a comment
Why the lack of outrage over smoking depicted in film and television?
January 20, 2014 To Senators Dick Durbin, Richard Blumenthal, Sherrod Brown, and Edward Markey
Posted in - Opinion, Congress, FDA
Leave a comment
Alex Rodriguez’s PED schedule
January 12, 2014- By Steven E. Greer, MD CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor
Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology
Leave a comment
Twitter interview with banned-for-life Wall Street tech analyst Henry Blodget
January 11, 2014- By Steven E. Greer, MD Disgraced Wall Street sell-side technology sector analyst, Henry Blodget, who was banned for life by
Posted in - Opinion, Congress
Leave a comment
Harvard professors feel the impact in their pocketbooks of the ACA law that they helped pass
Update January 5, 2014- This is now being reported in the New York Times, two-months after our reporting.
Posted in - Opinion, CMS, Harvard
Leave a comment
Laws governing genetic tests
December 19, 2013– Interviewed by Steven E. Greer, MD In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses
Posted in Columbia, Congress, FDA, Genetics
Leave a comment
The finances of TAVI: do prices have to come down?
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses … Continue reading
Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS
Leave a comment
TAVI: Comparing CoreValve to Sapien
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
The clinical hurdles to prescribing CGM
October 31, 2014– Interviewed by Steven E. Greer, MD The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM)
Did the GOP shut down the government just to please a special interest industry lobby?
October 19, 2013- By Steven E. Greer MD The United States government was partially shut down for more than two weeks in October.
Posted in - Medical Devices, - Opinion, Congress
Leave a comment
Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.
October 23, 2013- Interviewed by Steven E. Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer.
A Bridge Too Far: Patient classifications for LVAD reimbursement
September 16, 2013- By Ashish Shah, MD, Cardiac transplant surgeon, The Johns Hopkins Medical Center Left ventricular assist devices (LVADs) arose from the ashes of the total artificial heart era.
Posted in - Opinion, Cardiac surgery, CMS, Johns Hopkins
Leave a comment
Little guy challenges Dr. Oz over copyright infringement and wins
September 12, 2013- By Steven E. Greer, MD Under certain circumstances, copyrighted text or video content can be used by others without
Posted in - Opinion, Cardiac surgery, Congress
Leave a comment
Exclusive: CEO of Komen for the Cure never stepped down as announced in 2012
June 6, 2013- By Steven E. Greer, MD The breast cancer research foundation Komen for the Cure, founded by Nancy Brinker, got into hot water in 2012
Posted in - Policy, Oncology
Leave a comment
FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs
Interviewed by Steven E. Greer, MD
Posted in - Pharma, FDA
Leave a comment
What happens next with the ACA law?
May 20, 2013- Interviewed by Steven E. Greer, MD
Posted in CMS, Congress
Leave a comment
Reasons for permanent slowdowns in healthcare spending growth
May 17, 2013- Interviewed by Steven E. Greer, MD Since 2010,
Posted in CMS, Harvard
Leave a comment